cb-012
caribou
['cb-012', 'cll', 'caribou']
caribou biosciences presents new preclinical data on cb-012, an allogeneic anti-cll-1 car-t cell therapy, at the 2023 aacr annual meeting - globenewswire $crbu 
EDIT,CRSP,CRBU,DTIL, PACB,CLLS,NTLA,BEAM,SGMO, BLUE,VERV,GRPH,PRME